Literature DB >> 18775352

The metabolic syndrome--from insulin resistance to obesity and diabetes.

Emily Jane Gallagher1, Derek LeRoith, Eddy Karnieli.   

Abstract

In today's society with the escalating levels of obesity, diabetes, and cardiovascular disease, the metabolic syndrome is receiving considerable attention and is the subject of much controversy. Greater insight into the mechanism(s) behind the syndrome may improve our understanding of how to prevent and best manage this complex condition.

Entities:  

Mesh：

Year:  2008        PMID： 18775352     DOI： 10.1016/j.ecl.2008.05.002

Source DB:  PubMed          Journal:  Endocrinol Metab Clin North Am        ISSN： 0889-8529            Impact factor:   4.741


  28 in total

1.  Is MIS-TLIF superior to open TLIF in obese patients?: A systematic review and meta-analysis.

Authors:  Jun Hao Tan; Gabriel Liu; Ruimin Ng; Nishant Kumar; Hee-Kit Wong; Gabriel Liu
Journal:  Eur Spine J       Date:  2018-06-01       Impact factor: 3.134

2.  Inhibition of tumor suppressor p53 preserves glycation-serum induced pancreatic beta-cell demise.

Authors:  Y Li; T Zhang; Q Huang; Y Sun; X Chang; H Zhang; Y Zhu; X Han
Journal:  Endocrine       Date:  2016-05-09       Impact factor: 3.633

Review 3.  Effects of spinal cord injury on body composition and metabolic profile - part I.

Authors:  Ashraf S Gorgey; David R Dolbow; James D Dolbow; Refka K Khalil; Camilo Castillo; David R Gater
Journal:  J Spinal Cord Med       Date:  2014-07-07       Impact factor: 1.985

4.  Effect of vitamin D replacement on indexes of insulin resistance in overweight elderly individuals: a randomized controlled trial.

Authors:  Ghada El-Hajj Fuleihan; Rafic Baddoura; Robert H Habib; Georges Halaby; Asma Arabi; Maya Rahme; Ravinder J Singh; Moustapha Kassem; Ziyad Mahfoud; Maha Hoteit; Rose T Daher; Mohamed-Faisal Kassir
Journal:  Am J Clin Nutr       Date:  2016-07-13       Impact factor: 7.045

5.  Non-alcoholic fatty liver disease: An early mediator predicting metabolic syndrome in obese children?

Authors:  Jun-Fen Fu; Hong-Bo Shi; Li-Rui Liu; Ping Jiang; Li Liang; Chun-Lin Wang; Xi-Yong Liu
Journal:  World J Gastroenterol       Date:  2011-02-14       Impact factor: 5.742

Review 6.  Management of the metabolic syndrome and type 2 diabetes through lifestyle modification.

Authors:  Faidon Magkos; Mary Yannakoulia; Jean L Chan; Christos S Mantzoros
Journal:  Annu Rev Nutr       Date:  2009       Impact factor: 11.848

7.  IGFBP-3, hypoxia and TNF-alpha inhibit adiponectin transcription.

Authors:  Giovanna Zappalà; Matthew M Rechler
Journal:  Biochem Biophys Res Commun       Date:  2009-03-24       Impact factor: 3.575

8.  Methylglyoxal impairs insulin signalling and insulin action on glucose-induced insulin secretion in the pancreatic beta cell line INS-1E.

Authors:  F Fiory; A Lombardi; C Miele; J Giudicelli; F Beguinot; E Van Obberghen
Journal:  Diabetologia       Date:  2011-08-23       Impact factor: 10.122

Review 9.  Physiological Changes and Pathological Pain Associated with Sedentary Lifestyle-Induced Body Systems Fat Accumulation and Their Modulation by Physical Exercise.

Authors:  Enrique Verdú; Judit Homs; Pere Boadas-Vaello
Journal:  Int J Environ Res Public Health       Date:  2021-12-17       Impact factor: 3.390

10.  Cardiac ryanodine receptor in metabolic syndrome: is JTV519 (K201) future therapy?

Authors:  U Deniz Dincer
Journal:  Diabetes Metab Syndr Obes       Date:  2012-04-05       Impact factor: 3.168
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.